Management of Symptomatic Hypocalcemia
Initial Treatment
- The American College of Cardiology recommends administering calcium gluconate 50-100 mg/kg IV slowly with continuous ECG monitoring as the first-line intervention for symptomatic hypocalcemia, with a preferred infusion rate not exceeding 200 mg/minute in adults to avoid hypotension, bradycardia, and cardiac arrhythmias 3, 1
- Calcium gluconate is the preferred treatment, containing 90 mg elemental calcium per 10 mL of 10% solution, due to its lower risk of cardiac complications compared to calcium chloride 1
Diagnosis and Monitoring
- The Endocrine Society suggests measuring serum calcium every 4-6 hours during intermittent infusions and assessing for Chvostek's sign and Trousseau's sign to gauge neuromuscular irritability 1
- Checking magnesium levels immediately is crucial, as hypomagnesemia can prevent successful calcium correction and must be repleted concurrently with IV magnesium sulfate, with a target level above 1.0 mg/dL 1, 2
Concurrent Investigations
- The National Institute of Diabetes and Digestive and Kidney Diseases recommends obtaining ionized calcium, magnesium, PTH, phosphorus, creatinine, and 25-hydroxyvitamin D to determine the underlying etiology of hypocalcemia 1, 5
- A 12-lead ECG should be performed to assess for prolonged QT interval and cardiac manifestations, with a focus on identifying potential arrhythmias 1, 5
Addressing Hyponatremia
- The American Heart Association suggests addressing mild hyponatremia (132 mmol/L) with fluid restriction (1 L/day) if SIADH is suspected, or with appropriate treatment based on volume status assessment, after the life-threatening hypocalcemia is corrected and the patient is stabilized 4
- Rapid correction of chronic hyponatremia should be avoided (not exceeding 8 mmol/L over 24 hours) to prevent osmotic demyelination syndrome, with a target correction rate of less than 0.5 mmol/L/hour 4